Identifying predictors for good lithium response – A retrospective analysis of 100 patients with bipolar disorder using a life-charting method - 06/04/09
, Anna Ehnvall b, Jerker Hetta a, Göran Isacsson a, Hans Ågren c
Corresponding author. Tel./fax: +46 8 585 857 08.Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
| páginas | 7 |
| Iconografías | 1 |
| Vídeos | 0 |
| Otros | 0 |
Abstract |
Purpose |
Our aim was to investigate bipolar patients in order to test the validity of various outcome measures and to identify prognostic predictors for pharmacological treatment.
Material and method |
One hundred patients were interviewed using a computerized life-charting program in a descriptive, retrospective analysis. The concept “Burden of illness” was defined as a combination of severity and duration of episodes. Response to treatment was defined as the difference in burden before and after treatment, a low burden during treatment, and freedom of episodes for at least 3 years after insertion of treatment.
Results |
The absence of mixed episodes and a high initial burden predicted a good response measured as the difference in burden. If remission for 3 years or a low burden during lithium treatment was used, the absence of rapid cycling and of mixed episodes were the most important predictors. The severity of illness before treatment had no impact.
Discussion and conclusion |
We suggest the use of absolute measures of severity during treatment as the most appropriate measure of the outcome. Furthermore, our data provide corroboration that treatment with lithium ameliorates the prognosis of the illness, but that mixed episodes and rapid cycling predict a poorer response to lithium.
El texto completo de este artículo está disponible en PDF.Keywords : Bipolar disorder, Treatment outcome, Lithium
Esquema
Vol 24 - N° 3
P. 171-177 - avril 2009 Regresar al número
Artículo precedente
- How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- F.C.J. Starrenburg, J.P.A.M. Bogers
- Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: A pilot study
- Ashish Kumar Kakkar, H.S. Rehan, K.E.S. Unni, Neeraj Kumar Gupta, Deepti Chopra, Dinesh Kataria
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?